DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
MobiHealthNews

DEA, HHS extend telemedicine flexibilities for remote prescribing of controlled substances

The extension allows providers to continue remotely prescribing Schedule II–V controlled substances under specific conditions to prevent a disruptive "telemedicine cliff." ...
Healthcare Dive

DEA proposes long-awaited rule for telehealth controlled substance prescriptions

However, telehealth advocates raised concerns about restrictions included in the rule, with one group asking President-elect Donald Trump to withdraw the proposal. Before the COVID-19 pandemic, ...
WKRN-TV

‘Designer Xanax’ designated Schedule I controlled substance in Kentucky

FRANKFORT, Ky. (WOWK) — Kentucky Gov. Andy Beshear announced Monday that bromazolam, also known as “Designer Xanax,” received an emergency designation as a Schedule I controlled substance. As a ...